GSK share buyback

Anonymous

Guest
Well today was a mixed bag of news. First, the LLY Global Shares Options expired. Boo hoo. I told my husband that LLY will never hit $70 per share again, ever, laughing and tossing the notice into the fireplace.

However, a bit of news about GSK was very welcome. They are backing off from the FIPNET approach, and selling a couple billion $$$ worth of Quest. With that money, they hope to repurchase stock. The dividend is 5.6% and these folks are very well diversified in their portfolio. Gotta love the Brits.

Well time to pull the plug on my LLY holdings, and roll the $$$ into GSK. Check out their product portfolio some time. It's admirable. Maybe 100 years ago LLY was that ingenious, but not for the past several decades.

Time to reallocate some senior management, in my opinion. I really truly love GSK for what it offers, as a consumer and as a soon-to-be investress. How many LLY products would you purchase for your own consumption? Hmmmmmmmmmm?
 












GSK is not a one-trick pony

GlaxoSmithKline plc, together with its subsidiaries, engages in the discovery, development, manufacture, and marketing of pharmaceutical products, over the counter (OTC) medicines, and health related consumer products. The company offers prescription medicines to treat a range of conditions, such as infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer. It also markets approximately 25 vaccines to prevent life-threatening or crippling illnesses, such as hepatitis A, hepatitis B, diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio, typhoid, influenza, and bacterial meningitis. In addition, the company offers OTC medicines, such as alli, a weight loss medicine; Gaviscon, an antacid product; Panadol, a paracetamol-based pain reliever; smoking control products under NiQuitin and Nicorette names; and other brands, including Breathe Right nasal strips and snore relief products. Its oral healthcare products primarily comprise Aquafresh, a range of toothpastes, toothbrushes, and mouthwashes; and Sensodyne, a range of toothbrushes, toothpastes, mouthwashes, and dental floss. Further, the company provides nutritional healthcare products, such as Lucozade, a range of energy and sports drinks; Horlicks, a nutritional drink made from wheat, milk, and malted barley; and Ribena, a blackcurrant juice-based drink. Additionally, it offers products for dermatological treatments, pain relief, allergy treatment, cold and flu treatment, gastrointestinal conditions, feminine hygiene, nicotine replacement therapy, and HIV treatment. GlaxoSmithKline operates in the United States, Europe, China, Japan, the Middle East, Africa, Latin America, and Canada. It has a research collaboration with Eyegate Pharmaceuticals, Inc. to evaluate the delivery of the company’s therapies to the anterior and posterior tissues of the eye using the EyeGate II delivery system. The company was founded in 1935 and is based in Brentford, the United Kingdom.
 












Sorry, what is FIPNET?

FIPNET is a failed business strategy from the 70's that our ivy league CEO dug out of a trash can, relabeled and blessed it as our own. As a result, our stock is down 70% since the strategy was put in place. Thousands have been laid off, with thousands more planned. The only positive outcome has been the bonuses received by our CEO and his band of useless cronies. As the company slides into an abyss, their retirement plans get sweeter.